# EDGAR Filing Document

**Accession Number:** 0001611747
**File Stem:** 0001948744-26-000001
**Filing Date:** 2026-2
**Character Count:** 10411
**Document Hash:** 6f127aff22b5b0b9e650384e59a89d2c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001948744-26-000001.hdr.sgml**: 20260217

**ACCESSION NUMBER**: 0001948744-26-000001

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260217

**DATE AS OF CHANGE**: 20260217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Scinai Immunotherapeutics Ltd.
- **CENTRAL INDEX KEY:** 0001611747
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-89384
- **FILM NUMBER:** 26639170

**BUSINESS ADDRESS:**
- **STREET 1:** JERUSALEM BIOPARK, 2ND FLOOR
- **STREET 2:** HADASSAH EIN KEREM CAMPUS
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 00000
- **BUSINESS PHONE:** 972-8-9302529

**MAIL ADDRESS:**
- **STREET 1:** JERUSALEM BIOPARK, 2ND FLOOR
- **STREET 2:** HADASSAH EIN KEREM CAMPUS
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 00000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BiondVax Pharmaceuticals Ltd.
- **DATE OF NAME CHANGE:** 20140624
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STONE DANIEL E.
- **CENTRAL INDEX KEY:** 0001948744

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 1200 BRICKELL AVENUE, #1470
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33131

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 6)**

**Issuer:** Scinai Immunotherapeutics Ltd.

**Title of Class of Securities:** American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

**CUSIP Number:** 09073Q203

**Date of Event Which Requires Filing of this Statement:** 12/31/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>STONE DANIEL E. | Names of Reporting Persons<br>STONE DANIEL E. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>346667 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>346667 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>346667 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>346667 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.9% | Percent of Class Represented by Amount in Row (9)<br>9.9% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

---

| 1. | Names of Reporting Persons<br>RK Stone Miami, LLC | Names of Reporting Persons<br>RK Stone Miami, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>FL | Citizenship or Place of Organization<br>FL |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>237867 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>237867 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>237867 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>237867 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>6.71% | Percent of Class Represented by Amount in Row (9)<br>6.71% |
| 12. | Type of Reporting Person (See Instructions) | Type of Reporting Person (See Instructions) |

**Comment for Type of Reporting Person:** Based on 13,872,899,584 ordinary shares outstanding asof December 31, 2025, as disclosed by the issuer on February 15, 2026. Includes 107,000
American Depositary Shares (ADSs) held directly by the Reporting Person, 200,000 ADSs held by RK
Stone Miami, LLC ("RK") and 37,867 ADSs issuable upon exercise of pre-funded warrants held by
RK. On September 22, 2025, RK exercised 200,000 warrants. As of December 31, 2025, RK holds
200,000 ADSs and 283,426 ADS pre-funded warrants, which may not be exercised if such exercisewould result in beneficial ownership by RK, together with its affiliates (which include the Reporting
Person) and certain other persons, of greater than 9.99% of the ordinary shares. As disclosed in the
Schedule 13G amendment filed with the Securities and Exchange Commission on January 24, 2025,future issuances of ordinary shares or ADSs by the issuer to third parties are expected to causeadditional amounts of pre-funded warrants to become exercisable within the foregoing limitation,without increasing the reporting person's beneficial ownership percentage.

---

**Item 1(a). Name of Issuer:**
Scinai Immunotherapeutics Ltd.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, ISRAEL
00000

**Item 2(a). Name of Person Filing:**
STONE DANIEL E.

RK Stone Miami, LLC

**Item 2(b). Address of Principal Business Office:**
1200 BRICKELL AVENUE, #1470
MIAMI, Florida
33131

**Item 2(c). Citizenship:**
STONE DANIEL E. - UNITED STATES

RK Stone Miami, LLC - FLORIDA

**Item 2(d). Title of Class of Securities:**
American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

**Item 2(e). CUSIP Number:**
09073Q203

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

584,534

**(b) Percent of class:**

16.61

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

STONE DANIEL E. - 346,667
RK Stone Miami, LLC - 237,867

**(ii) Shared power to vote or to direct the vote:**

STONE DANIEL E. - 0
RK Stone Miami, LLC - 0

**(iii) Sole power to dispose or to direct the disposition of:**

STONE DANIEL E. - 346,667
RK Stone Miami, LLC - 237,867

**(iv) Shared power to dispose or to direct the disposition of:**

STONE DANIEL E. - 0
RK Stone Miami, LLC - 0

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**STONE DANIEL E.**

**Date:** 02/13/2026

**By:** /s/ Daniel E. Stone

**Name & Title:** Stone Daniel E.

**RK Stone Miami, LLC**

**Date:** 02/13/2026

**By:** /s/ Daniel E. Stone

**Name & Title:** Sole Member - RK Stone Miami, LLC